These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9593598

  • 1. Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions.
    Song C, Leonard BE.
    Eur J Pharmacol; 1998 Mar 12; 345(1):79-87. PubMed ID: 9593598
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
    Debonnel G, Bergeron R, Monnet FP, De Montigny C.
    Neuroscience; 1996 Apr 12; 71(4):977-87. PubMed ID: 8684626
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats.
    Junien JL, Gue M, Bueno L.
    Neuropharmacology; 1991 Oct 12; 30(10):1119-24. PubMed ID: 1661865
    [Abstract] [Full Text] [Related]

  • 4. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
    Riviere PJ, Rao RK, Pascaud X, Junien JL, Porreca F.
    J Pharmacol Exp Ther; 1993 Mar 12; 264(3):1268-74. PubMed ID: 8450462
    [Abstract] [Full Text] [Related]

  • 5. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
    Gué M, Yoneda M, Mönnikes H, Junien JL, Taché Y.
    Br J Pharmacol; 1992 Nov 12; 107(3):642-7. PubMed ID: 1472962
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors.
    Gue M, Junien JL, Del Rio C, Bueno L.
    J Pharmacol Exp Ther; 1992 Jun 12; 261(3):850-5. PubMed ID: 1318376
    [Abstract] [Full Text] [Related]

  • 7. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
    Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C.
    Br J Pharmacol; 1994 Jun 12; 112(2):709-15. PubMed ID: 8075892
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
    Monnet FP, Debonnel G, Fournier A, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec 12; 263(3):1219-25. PubMed ID: 1469630
    [Abstract] [Full Text] [Related]

  • 9. Effects of JO 1784, a selective sigma ligand, on the autoradiographic localization of M1 and M2 muscarinic receptor subtypes in trimethyltin treated rats.
    Earley B, Glennon M, Leonard BE, Junien JL.
    Neurochem Int; 1995 Jun 12; 26(6):559-70. PubMed ID: 7670359
    [Abstract] [Full Text] [Related]

  • 10. Effects of a new sigma ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats.
    Pascaud XB, Chovet M, Soulard P, Chevalier E, Roze C, Junien JL.
    Gastroenterology; 1993 Feb 12; 104(2):427-34. PubMed ID: 8425684
    [Abstract] [Full Text] [Related]

  • 11. The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat.
    O'Connell AW, Earley B, Leonard BE.
    Pharmacol Toxicol; 1996 May 12; 78(5):296-302. PubMed ID: 8737963
    [Abstract] [Full Text] [Related]

  • 12. Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat.
    Song C, Earley B, Leonard BE.
    Neuropsychobiology; 1997 May 12; 35(4):200-4. PubMed ID: 9246222
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site.
    Rivière PJ, Pascaud X, Junien JL, Porreca F.
    Eur J Pharmacol; 1990 Oct 23; 187(3):557-9. PubMed ID: 1705893
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL.
    Brain Res; 1991 Apr 19; 546(2):282-6. PubMed ID: 1676927
    [Abstract] [Full Text] [Related]

  • 15. Central action of sigma receptor ligand, JO 1784, to suppress CRF-induced inhibition of gastric function in conscious rats.
    Yoneda M, Junien JL, Taché Y.
    Eur J Pharmacol; 1992 Nov 17; 223(2-3):197-9. PubMed ID: 1478267
    [Abstract] [Full Text] [Related]

  • 16. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B, Debonnel G.
    Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654
    [Abstract] [Full Text] [Related]

  • 17. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R, de Montigny C, Debonnel G.
    Br J Pharmacol; 1997 Apr 05; 120(7):1351-9. PubMed ID: 9105712
    [Abstract] [Full Text] [Related]

  • 18. Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant.
    Akunne HC, Zoski KT, Whetzel SZ, Cordon JJ, Brandon RM, Roman F, Pugsley TA.
    Neuropharmacology; 2001 Jul 05; 41(1):138-49. PubMed ID: 11445194
    [Abstract] [Full Text] [Related]

  • 19. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia.
    O'Neill M, Caldwell M, Earley B, Canney M, O'Halloran A, Kelly J, Leonard BE, Junien JL.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):217-25. PubMed ID: 7498313
    [Abstract] [Full Text] [Related]

  • 20. The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization.
    Urani A, Romieu P, Portales-Casamar E, Roman FJ, Maurice T.
    Psychopharmacology (Berl); 2002 Aug 05; 163(1):26-35. PubMed ID: 12185397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.